Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Aromatase

From Wikipedia, the free encyclopedia
Enzyme involved in estrogen production

CYP19A1
Available structures
PDBOrtholog search:PDBeRCSB
List of PDB id codes

3EQM,3S79,3S7S,4GL5,4GL7,4KQ8

Identifiers
AliasesCYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM, cytochrome P450 family 19 subfamily A member 1
External IDsOMIM:107910;MGI:88587;HomoloGene:30955;GeneCards:CYP19A1;OMA:CYP19A1 - orthologs
Gene location (Human)
Chromosome 15 (human)
Chr.Chromosome 15 (human)[1]
Chromosome 15 (human)
Genomic location for CYP19A1
Genomic location for CYP19A1
Band15q21.2Start51,208,057bp[1]
End51,338,601bp[1]
Gene location (Mouse)
Chromosome 9 (mouse)
Chr.Chromosome 9 (mouse)[2]
Chromosome 9 (mouse)
Genomic location for CYP19A1
Genomic location for CYP19A1
Band9 A5.3|9 29.49 cMStart54,073,221bp[2]
End54,175,394bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • placenta

  • right testis

  • left testis

  • testicle

  • tibial nerve

  • gonad

  • germinal epithelium

  • subcutaneous adipose tissue

  • right ovary

  • left coronary artery
Top expressed in
  • spermatocyte

  • secondary oocyte

  • zygote

  • primary oocyte

  • cumulus cell

  • ovarian follicle cell

  • spermatid

  • meninges

  • testicle

  • seminiferous tubule
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

1588

13075

Ensembl

ENSG00000137869

ENSMUSG00000032274

UniProt

P11511

P28649

RefSeq (mRNA)
NM_000103
NM_001347248
NM_001347249
NM_001347250
NM_001347251

NM_001347252
NM_001347253
NM_001347254
NM_001347255
NM_001347256
NM_031226

NM_007810
NM_001348171
NM_001348172
NM_001348173

RefSeq (protein)
NP_000094
NP_001334177
NP_001334178
NP_001334179
NP_001334180

NP_001334181
NP_001334182
NP_001334183
NP_001334184
NP_001334185
NP_112503

NP_001335100
NP_001335101
NP_001335102
NP_031836

Location (UCSC)Chr 15: 51.21 – 51.34 MbChr 9: 54.07 – 54.18 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Aromatase (EC1.14.14.14), also calledestrogen synthetase orestrogen synthase, is anenzyme responsible for a key step in thebiosynthesis ofestrogens. It isCYP19A1, a member of thecytochrome P450 superfamily, which aremonooxygenases that catalyze many reactions involved insteroidogenesis. In particular, aromatase is responsible for thearomatization ofandrogens intoestrogens. The enzyme aromatase can be found in many tissues includinggonads (granulosa cells),brain,adipose tissue,placenta,blood vessels,skin, andbone, as well as in tissue ofendometriosis,uterine fibroids,breast cancer, andendometrial cancer.[citation needed] It is an important factor insexual development.

Function

[edit]

Aromatase islocalized in theendoplasmic reticulum where it is regulated by tissue-specificpromoters that are in turn controlled byhormones,cytokines, and other factors. It catalyzes the last steps of estrogen biosynthesis from androgens (specifically, it transformsandrostenedione toestrone andtestosterone toestradiol). These steps include three successivehydroxylations of the 19-methyl group of androgens, followed by simultaneous elimination of the methyl group asformate and aromatization of the A-ring.

Androstenedione + 3O2 + 3NADPH + 3H+{\displaystyle \rightleftharpoons }Estrone + Formate + 4H2O + 3NADP+
Testosterone + 3O2 + 3NADPH + 3H+{\displaystyle \rightleftharpoons }17β-estradiol + Formate + 4H2O + 3NADP+
General reaction for the conversion oftestosterone toestradiol catalyzed by aromatase. Steroids are composed of four fusedrings (labeled A-D). Aromatase converts the ring labeled "A" into anaromatic state.
Catalytic mechanism of aromatase for the conversion ofandrostenedione toestrone. Themethyl group isoxidized and subsequentlyeliminated.[5]

Expression

[edit]

Aromatase is expressed in thegonads,placenta,brain,adipose tissue,bone, and othertissues.[citation needed] It is almost undetectable in adult humanliver.[6]

Genomics

[edit]

The gene expresses two transcript variants.[7] In humans, thegene CYP19, located onchromosome 15q21.1, encodes aromatase.[8] The gene has nine codingexons and a number of alternative non-coding first exons that regulate tissue specific expression.[9]

CYP19 is present in an early-divergingchordate, thecephalochordateamphioxus (the Floridalancelet,Branchiostoma floridae), but not in the earlier divergingtunicateCiona intestinalis. Thus, the aromatase gene evolved early in chordate evolution and does not appear to be present in nonchordateinvertebrates (e.g.insects,molluscs,echinoderms,sponges,corals). However,estrogens may be synthesized in some of these organisms, via other unknown pathways.

Activity

[edit]

Aromatase activity is increased byage,obesity,insulin,gonadotropins, andalcohol.[10] It also appears to be enhanced in certain estrogen-dependent local tissue next to breast tissue,endometrial cancer,endometriosis, anduterine fibroids.[10]

Aromatase activity is decreased or antagonized byprolactin,anti-Müllerian hormone andglyphosate.[10]

Role in sex-determination

[edit]

Aromatase is generally highly present during the differentiation of ovaries.[11][12] It is also susceptible to environmental influences, particularly temperature. In species withtemperature-dependent sex determination, aromatase is expressed in higher quantities at temperatures that yield female offspring.[11] Despite the fact that data suggest temperature controls aromatase quantities, other studies have shown that aromatase can overpower the effects of temperature: if exposed to more aromatase at a male-producing temperature, the organism will develop female and conversely, if exposed to less aromatase at female-producing temperatures, the organism will develop male (seesex reversal).[11] In organisms that develop through genetic sex determination, temperature does not affect aromatase expression and function, suggesting that aromatase is the target molecule for temperature during TSD[11] (for challenges to this argument, seetemperature-dependent sex determination). It varies from species to species whether it is the aromatase protein that has different activity at different temperatures or whether the amount of transcription undergone by the aromatase gene is what is temperature-sensitive, but in either case, differential development is observed at different temperatures.[13]

Role in neuroprotection

[edit]

Aromatase in the brain is usually only expressed inneurons. However, following penetrative brain injury of both mice andzebra finches, it has been shown to be expressed inastrocytes.[14] It has also been shown to decreaseapoptosis following brain injury in zebra finches.[15] This is thought to be due to theneuroprotective actions of estrogens, including estradiol. Research has found that twopro-inflammatory cytokines,interleukin-1β (IL-1β) andinterleukin-6 (IL-6), are responsible for the induction of aromatase expression in astrocytes following penetrative brain injury in the zebra finch.[16]

Disorders

[edit]

Aromatase excess syndrome

[edit]
Main article:Aromatase excess syndrome

A number of investigators have reported on a rather rare syndrome of excess aromatase activity. In boys, it createsgynecomastia, and in girls,precocious puberty andgigantomastia. In both sexes, earlyepiphyseal closure leads to short stature. This condition is due to mutations in the CYP19A1 gene which encodes aromatase.[17] It is inherited in an autosomal dominant fashion.[18] It has been suggested that the pharaohAkhenaten and other members of his family may have had this disorder,[19] but more recent genetic tests suggest otherwise.[20] It is one of the causes of familial precocious puberty—a condition first described in 1937.[21]

Aromatase deficiency syndrome

[edit]
Main article:Aromatase deficiency

This syndrome is due to aloss of function mutation within the CYP19A1 gene and is inherited in anautosomal recessive way. Accumulations of androgens during pregnancy may lead tovirilization of a female at birth (males are not affected). Females will have primaryamenorrhea. Individuals of both sexes will be tall, as lack of estrogen preventsepiphyseal closure.

Inhibition of aromatase

[edit]

The followingnatural products have been found to have inhibiting effects on aromatasein vitro:

Clinically used aromatase inhibitors

[edit]
Main article:Aromatase inhibitor

Aromatase inhibitors have become useful in the management of patients withbreast cancer whose tumor was found to beestrogen receptor positive.[33] Inhibitors that are in current clinical use includeanastrozole,exemestane, andletrozole.

See also

[edit]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000137869Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000032274Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Vaz AD (2003). "Chapter 1: Cytochrome activation by cytochromes P450: a role for multiple oxidants in the oxidation of substrates". In Fisher M, Lee JK, Obach RE (eds.).Drug metabolizing enzymes: cytochrome P450 and other enzymes in drug discovery and development. Lausanne, Switzerland: FontisMedia SA.ISBN 978-0-8247-4293-5.
  6. ^Hata S, Miki Y, Saito R, Ishida K, Watanabe M, Sasano H (June 2013)."Aromatase in human liver and its diseases".Cancer Med.2 (3):305–15.doi:10.1002/cam4.85.PMC 3699842.PMID 23930207.
  7. ^"Entrez Gene: CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1".
  8. ^Toda K, Shizuta Y (April 1993)."Molecular cloning of a cDNA showing alternative splicing of the 5'-untranslated sequence of mRNA for human aromatase P-450".European Journal of Biochemistry.213 (1):383–9.doi:10.1111/j.1432-1033.1993.tb17772.x.PMID 8477708.
  9. ^Czajka-Oraniec I, Simpson ER (2010). "Aromatase research and its clinical significance".Endokrynologia Polska.61 (1):126–34.PMID 20205115.
  10. ^abcHussain A, Gilloteaux J (September 2020)."The human testes: Estrogen and ageing outlooks".Translational Research in Anatomy.20 100073.doi:10.1016/j.tria.2020.100073.ISSN 2214-854X.S2CID 219001284.
  11. ^abcdDuffy TA, Picha ME, Won ET, Borski RJ, McElroy AE, Conover DO (August 2010). "Ontogenesis of gonadal aromatase gene expression in atlantic silverside (Menidia menidia) populations with genetic and temperature-dependent sex determination".Journal of Experimental Zoology Part A.313 (7):421–31.Bibcode:2010JEZA..313..421D.doi:10.1002/jez.612.PMID 20623799.
  12. ^Kohno S, Katsu Y, Urushitani H, Ohta Y, Iguchi T, Guillette LJ (2010)."Potential contributions of heat shock proteins to temperature-dependent sex determination in the American alligator".Sexual Development.4 (1–2):73–87.doi:10.1159/000260374.PMC 2855287.PMID 19940440.
  13. ^Gilbert SF (2010).Developmental biology. Sunderland, Mass: Sinauer Associates.ISBN 978-0-87893-384-6.
  14. ^Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB (March 1999). "Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair".Neuroscience.89 (2):567–78.doi:10.1016/s0306-4522(98)00340-6.PMID 10077336.S2CID 24689059.
  15. ^Saldanha CJ, Rohmann KN, Coomaralingam L, Wynne RD (August 2005). "Estrogen provision by reactive glia decreases apoptosis in the zebra finch (Taeniopygia guttata)".Journal of Neurobiology.64 (2):192–201.doi:10.1002/neu.20147.PMID 15818556.
  16. ^Duncan KA, Saldanha CJ (July 2011)."Neuroinflammation induces glial aromatase expression in the uninjured songbird brain".Journal of Neuroinflammation.8 (81): 81.doi:10.1186/1742-2094-8-81.PMC 3158750.PMID 21767382.
  17. ^Fukami M, Shozu M, Ogata T (2012)."Molecular bases and phenotypic determinants of aromatase excess syndrome".International Journal of Endocrinology.2012 584807.doi:10.1155/2012/584807.PMC 3272822.PMID 22319526.
  18. ^Fukami M, Shozu M, Soneda S, Kato F, Inagaki A, Takagi H, et al. (June 2011)."Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants".The Journal of Clinical Endocrinology and Metabolism.96 (6): E1035-43.doi:10.1210/jc.2011-0145.PMID 21470988.
  19. ^Braverman IM, Redford DB, Mackowiak PA (April 2009). "Akhenaten and the strange physiques of Egypt's 18th dynasty".Annals of Internal Medicine.150 (8):556–60.doi:10.7326/0003-4819-150-8-200904210-00010.PMID 19380856.S2CID 24766974.
  20. ^Seshadri KG (May 2012)."The breasts of Tutankhamun".Indian Journal of Endocrinology and Metabolism.16 (3):429–30.doi:10.4103/2230-8210.95696.PMC 3354854.PMID 22629513.
  21. ^Ziora K, Oświecimska J, Geisler G, Broll-Waśka K, Szalecki M, Dyduch A (2006). "[Familial precocious puberty -- a variant of norm or pathology?]".Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego (in Polish).12 (1):53–8.PMID 16704862.
  22. ^abcdBalunas MJ, Su B, Brueggemeier RW, Kinghorn AD (August 2008)."Natural products as aromatase inhibitors".Anti-Cancer Agents in Medicinal Chemistry.8 (6):646–82.doi:10.2174/1871520610808060646.PMC 3074486.PMID 18690828.
  23. ^Satoh K, Sakamoto Y, Ogata A, Nagai F, Mikuriya H, Numazawa M, et al. (July 2002). "Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats".Food and Chemical Toxicology.40 (7):925–33.doi:10.1016/S0278-6915(02)00066-2.PMID 12065214.
  24. ^Kapiszewska M, Miskiewicz M, Ellison PT, Thune I, Jasienska G (May 2006)."High tea consumption diminishes salivary 17beta-estradiol concentration in Polish women".The British Journal of Nutrition.95 (5):989–95.doi:10.1079/BJN20061755.hdl:11315/483.PMID 16611391.
  25. ^Le Bail JC, Pouget C, Fagnere C, Basly JP, Chulia AJ, Habrioux G (January 2001). "Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities".Life Sciences.68 (7):751–61.doi:10.1016/S0024-3205(00)00974-7.PMID 11205867.
  26. ^Ye L, Chan FL, Chen S, Leung LK (October 2012). "The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice".The Journal of Nutritional Biochemistry.23 (10):1230–7.doi:10.1016/j.jnutbio.2011.07.003.PMID 22209285.
  27. ^Doering IL, Richter E (April 2009). "Inhibition of human aromatase by myosmine".Drug Metabolism Letters.3 (2):83–6.doi:10.2174/187231209788654045.PMID 19601869.
  28. ^Biegon A, Kim SW, Logan J, Hooker JM, Muench L, Fowler JS (April 2010)."Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons".Biological Psychiatry.67 (8):774–7.doi:10.1016/j.biopsych.2010.01.004.PMC 2904480.PMID 20188349.
  29. ^Wang Y, Lee KW, Chan FL, Chen S, Leung LK (July 2006)."The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells".Toxicological Sciences.92 (1):71–7.doi:10.1093/toxsci/kfj190.PMID 16611627.
  30. ^Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goralczyk R, et al. (June 2004)."Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model".FASEB Journal.18 (9):1019–21.doi:10.1096/fj.03-1116fje.PMID 15084515.S2CID 26424745.
  31. ^Om AS, Chung KW (April 1996)."Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors in rat liver".The Journal of Nutrition.126 (4):842–8.doi:10.1093/jn/126.4.842.PMID 8613886.
  32. ^Chen S, Oh SR, Phung S, Hur G, Ye JJ, Kwok SL, et al. (December 2006)."Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus)".Cancer Research.66 (24):12026–34.doi:10.1158/0008-5472.CAN-06-2206.PMID 17178902.
  33. ^"Aromatase Inhibitors".Breastcancer.org. 29 October 2020.

Further reading

[edit]

External links

[edit]
Mevalonate pathway
ToHMG-CoA
Ketogenesis
ToMevalonic acid
ToDMAPP
Geranyl-
Tocholesterol
Tolanosterol
7-Dehydrocholesterol path
Desmosterol path
ToBile acids
Steroidogenesis
Topregnenolone
Tocorticosteroids
Tosex hormones
Toandrogens
Toestrogens
Other/ungrouped
CYP1
CYP2
CYP3 (CYP3A)
CYP4
CYP5-20
CYP21-49
CYP51-69
CYP71-99
CYP101-281
CYP301-499
CYP501-699
CYP701-999
1.14.11:2-oxoglutarate
1.14.13:NADH orNADPH
1.14.14: reducedflavin orflavoprotein
1.14.15: reducediron–sulfur protein
1.14.16: reducedpteridine (BH4 dependent)
1.14.17: reducedascorbate
1.14.18-19: other
1.14.99 - miscellaneous
Activity
Regulation
Classification
Kinetics
Types
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Aromatase&oldid=1321378215"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp